Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-21-004863
Filing Date
2021-10-13
Accepted
2021-10-13 16:02:04
Documents
1
Period of Report
2021-10-12

Document Format Files

Seq Description Document Type Size
1 form4-10132021_011054.html 4  
1 form4-10132021_011054.xml 4 3532
  Complete submission text file 0001415889-21-004863.txt   4927
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Issuer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 7TH AVENUE NE ST. PETERSBURG FL 33701
Business Address
White Mark K. (Reporting) CIK: 0001786183 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39202 | Film No.: 211321268